TPXimpact
OrganizationHeard in 4 episodes across 1 show since May 2026
TPXimpact is a UK digital transformation consultancy that helps public- and private-sector organizations improve services, technology, and organizational change.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 1 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 2 |
| Oct 2026 | 1 |
| Nov 2026 | 0 |
Email alert
Email me when TPXimpact comes up on a podcast
One email a week at most, with the new episodes that mention TPXimpact. Free, no account needed, unsubscribe in one click.
What experts have said about TPXimpact
4 statements · 2 positive · 2 mixed
TPX Impact is growing into its valuation and retains a modest P/E
“And it's really growing into the valuation nicely. You've got still a reasonably modest PE.”
Open the episode · Morning Movers - Thu 15 Oct 2026Listen at 1:57
TPX Impact’s improving performance is making its valuation more reasonable.
“it's really growing into the valuation nicely”
Open the episode · Morning Movers - Thu 15 Oct 2026Listen at 1:57
TPX Impact is not overpriced if its outlook remains intact.
“we've got the forward PEs still in high single digits. So not overpriced, providing nothing goes wrong.”
Open the episode · Morning Movers - Thu 15 Oct 2026Listen at 2:19
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
4 episodes featuring TPXimpact, newest first
- Oct 15, 2026
Scott tracks Ghana Media and ThruVision’s market surgeUK Small/Mid Caps with Paul ScottOct 15, 2026 - Sep 18, 2026
Paul Scott returns after a ten-day illnessUK Small/Mid Caps with Paul ScottSep 18, 2026 - Sep 11, 2026
UK small caps defy gloomy macro headlinesUK Small/Mid Caps with Paul ScottSep 11, 2026 - May 8, 2026
Paul Scott revisits a disputed Novacyte market moveUK Small/Mid Caps with Paul ScottMay 8, 2026